Calendar

Sep
28
Thu
Alumni Career Series: Morgan Welsh Bernier @ Smith Seminar Room 1080, Physics Research Building
Sep 28 @ 11:30 am – 12:30 pm

A Career in Finance

Thursday, September 28, 2017 11:30 a.m. with reception to precede

Dr. Morgan Welsh Bernier, PhD

Marketing Data Scientist

JP Morgan Chase

 

Students interested in attending a luncheon with the speaker should contact Rachel Page(.257). Limited to 11 seats.

 

RSPV: https://osu.az1.qualtrics.com/jfe/form/SV_0i8kQvohDidKPGZ

Nov
13
Mon
2017 Russ Pitzer Lecture – J. Andrew McCammon @ 100 Stillman Hall
Nov 13 @ 4:10 pm – 5:10 pm

Lecturer: J. Andrew McCammon, University of California, San Diego

Title: Thermodynamics of Molecular Recognition

Light reception to follow in CBEC lobby

 

J. Andrew McCammon is the Joseph E. Mayer Chair Professor of Theoretical Chemistry and Distinguished Professor of Pharmacology at UCSD.   He received his B.A. from Pomona College, and his Ph.D. in chemical physics from Harvard University, where he worked with John Deutch (of MIT).  In 1976-78, he developed the computer simulation approach to protein dynamics in Martin Karplus’s lab at Harvard.  He joined the University of Houston as Assistant Professor of Chemistry in 1978, and became the M.D. Anderson Chair Professor of Chemistry in 1981. He moved to UCSD in 1995.  Professor McCammon has invented theoretical methods for accurately predicting and interpreting molecular recognition, rates of reactions, and other properties of chemical systems.  In addition to their fundamental interest, these methods play a growing role in the design of new drugs and other materials.  Professor McCammon is the author with Stephen Harvey of “Dynamics of Proteins and Nucleic Acids” (Cambridge University Press), and is the author or co-author of more than 800 publications in theoretical chemistry and biochemistry. More than 80 of his graduate students and postdoctoral fellows have secured tenured or tenure-track faculty positions at leading colleges and universities.  In the 1980’s, Professor McCammon guided the establishment of the computer-aided drug discovery program of Agouron Pharmaceuticals (now Pfizer Global Research and Development, La Jolla Laboratories), and contributed to the development of the widely prescribed HIV-1 protease inhibitor, Viracept (nelfinavir).  The McCammon group’s studies of HIV-1 integrase flexibility contributed to the discovery of the first in a new class of antiviral drugs by Merck & Co., named Isentress (raltegravir) and approved by the US FDA in 2007. Professor McCammon received the first George Herbert Hitchings Award for Innovative Methods in Drug Design from the Burroughs Wellcome Fund in 1987.  In 1995, he received the Smithsonian Institution’s Information Technology Leadership Award for Breakthrough Computational Science, sponsored by Cray Research.  He is the recipient of the American Chemical Society’s 2008 National Award for Computers in Chemical and Pharmaceutical Research.  He received the Joseph O. Hirschfelder Prize in Theoretical Chemistry for 2016-17 and the Russell M. Pitzer Award in Theoretical Chemistry in 2017. Professor McCammon is a Fellow of the American Academy of Arts and Sciences, the American Association for the Advancement of Science, the American Physical Society, and the Biophysical Society.  He is a Member of the US National Academy of Sciences.

 

Jan
25
Thu
Alumni Career Series: Michael Page @ Smith Seminar Room 1080, Physics Research Building
Jan 25 @ 11:30 am – 12:30 pm

A Career in a Department of Defense Laboratory

Thursday, January 25, 2018 11:30 a.m. with reception to precede

Dr. Michael Page, PhD

Research Physicist

Air Force Research Laboratory, Materials and Manufacturing Directorate

 

Students interested in attending a luncheon with the speaker should contact Rachel Page(.257). Limited to 11 seats.